日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transportation barriers, emergency room use, and mortality risk among US adults by cancer history

癌症病史与美国成年人交通障碍、急诊室使用情况和死亡风险的关系

Jiang, Changchuan; Yabroff, K Robin; Deng, Lei; Wang, Qian; Perimbeti, Stuthi; Shapiro, Charles L; Han, Xuesong

Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis

Oncotype Dx评分、HER2低表达与早期乳腺癌临床结局:一项基于国家癌症数据库的分析

Roy, Arya Mariam; Jiang, Changchuan; Perimbeti, Stuthi; Deng, Lei; Shapiro, Charles L; Gandhi, Shipra

Self-reported Transportation Barriers to Health Care Among US Cancer Survivors

美国癌症幸存者自述就医交通障碍

Jiang, Changchuan; Yabroff, K Robin; Deng, Lei; Wang, Qian; Perimbeti, Stuthi; Shapiro, Charles L; Han, Xuesong

Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis

新发转移性HER2低表达乳腺癌的临床结局:一项基于国家癌症数据库的分析

Jiang, Changchuan; Perimbeti, Stuthi; Deng, Lei; Shapiro, Charles L; Gandhi, Shipra

Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018

美国成年癌症幸存者慢性合并症:2002-2018年全国健康访问调查结果

Jiang, Changchuan; Deng, Lei; Karr, Matthew A; Wen, Yumeng; Wang, Qian; Perimbeti, Stuthi; Shapiro, Charles L; Han, Xuesong

Quality Care in Survivorship: Lessons Learned From the ASCO Quality Oncology Practice Initiative

生存期优质护理:从ASCO肿瘤质量实践倡议中汲取的经验教训

Shapiro, Charles L; Zubizarreta, Nicole; Moshier, Erin; Brockway, Julia P; Mandeli, John; Markham, Merry Jennifer; Kozlik, Mary May; Crist, Stephanie; Jacobsen, Paul B

A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies

一项针对2型神经纤维瘤病相关肿瘤和晚期实体恶性肿瘤患者的组蛋白去乙酰化酶抑制剂AR-42的I期临床试验

Collier, Katharine A; Valencia, Hugo; Newton, Herbert; Hade, Erinn M; Sborov, Douglas W; Cavaliere, Robert; Poi, Ming; Phelps, Mitch A; Liva, Sophia G; Coss, Christopher C; Wang, Jiang; Khountham, Soun; Monk, Paul; Shapiro, Charles L; Piekarz, Richard; Hofmeister, Craig C; Welling, D Bradley; Mortazavi, Amir

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study

维利帕尼联合卡铂间歇和持续给药方案治疗转移性乳腺癌的I期研究:安全性和[18F]-氟胸苷正电子发射断层扫描生物标志物研究

Wesolowski, Robert; Stover, Daniel G; Lustberg, Maryam B; Shoben, Abigail; Zhao, Meng; Mrozek, Ewa; Layman, Rachel M; Macrae, Erin; Duan, Wenrui; Zhang, Jun; Hall, Nathan; Wright, Chadwick L; Gillespie, Susan; Berger, Michael; Chalmers, Jeffrey J; Carey, Alahdra; Balasubramanian, Priya; Miller, Brandon L; Amaya, Peter; Andreopoulou, Eleni; Sparano, Joseph; Shapiro, Charles L; Villalona-Calero, Miguel Angel; Geyer, Susan; Chen, Alice; Grever, Michael R; Knopp, Michael V; Ramaswamy, Bhuvaneswari

Metastatic breast cancer patient perceptions of somatic tumor genomic testing

转移性乳腺癌患者对体细胞肿瘤基因组检测的看法

Adams, Elizabeth J; Asad, Sarah; Reinbolt, Raquel; Collier, Katharine A; Abdel-Rasoul, Mahmoud; Gillespie, Susan; Chen, James L; Cherian, Mathew A; Noonan, Anne M; Sardesai, Sagar; VanDeusen, Jeffrey; Wesolowski, Robert; Williams, Nicole; Shapiro, Charles L; Macrae, Erin R; Pilarski, Robert; Toland, Amanda E; Senter, Leigha; Ramaswamy, Bhuvaneswari; Lee, Clara N; Lustberg, Maryam B; Stover, Daniel G

Caring about bone-modifying agents (BMAs) in women with early-stage breast cancer

关注早期乳腺癌女性的骨调节剂(BMA)

Shapiro, Charles L